What is Manhattan Endoscopy?
Manhattan Endoscopy Center operates as a modern outpatient surgical facility in New York, concentrating on gastroenterology, hepatology, and gastrointestinal endoscopy. The center provides a comprehensive suite of diagnostic and therapeutic procedures, including critical services for colorectal cancer prevention and hemorrhoid treatment. Committed to delivering high-quality specialty care, Manhattan Endoscopy is staffed by experienced gastroenterologists dedicated to a patient-centered experience from initial consultation through recovery. Their acceptance of most major insurance plans, including Medicare and Medicaid, ensures broad accessibility to their specialized medical services.
How much funding has Manhattan Endoscopy raised?
Manhattan Endoscopy has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Manhattan Endoscopy?
The substantial capital infusion, particularly the recent major strategic investment, positions Manhattan Endoscopy for significant growth and operational enhancement. As a company in a large-scale late-stage funding phase, this financing is likely to be directed towards expanding service capacity, adopting advanced endoscopic technologies, and potentially broadening its geographic reach or service offerings within the gastroenterology and hepatology fields. The strategic nature of the investment suggests a focus on long-term value creation and market leadership, enabling Manhattan Endoscopy to further solidify its reputation for high-quality, accessible specialty care.
See full Manhattan Endoscopy company page
